Crown Laboratories Acquires StriVectin from L Catterton
August 26, 2021
Crown Laboratories, a Hildred Capital portfolio company, has entered into a definitive agreement to acquire StriVectin from L Catterton. StriVectin will operate as a wholly owned subsidiary within Crown's new Premium Skincare Division, with its president Cori Aleardi joining Crown's executive team; the deal was expected to close by mid-September 2021.
- Buyers
- Crown Laboratories
- Targets
- StriVectin
- Sellers
- L Catterton
- Platforms
- Crown Laboratories
- Industry
- Consumer Products
- Location
- New York, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Procter & Gamble to Acquire Thorne for $3.8 Billion
August 4, 2026
Healthcare Services
L_ Catterton signed a definitive agreement to sell Thorne to The Procter & Gamble Company for $3.8 billion in cash. The acquisition is intended to expand P&G’s science-backed health and wellness portfolio and strengthen its presence in self-care, preventive health, and personalized wellness.
-
Crown Affair Raises Series C Investment Led by Stride Consumer Partners
May 8, 2026
Consumer Products
Crown Affair, a modern haircare brand, announced a Series C investment led by Stride Consumer Partners. The round primarily includes secondary capital and comes as Crown Affair expands to all retail doors nationwide at Sephora.
-
Crown Laboratories Acquires Revance Therapeutics in $924M Merger
August 12, 2024
Healthcare Services
Crown Laboratories, Inc. entered into a merger agreement to acquire Revance Therapeutics, Inc. for $6.66 per share in cash, representing an enterprise value of $924 million. The deal closed after Crown commenced a tender offer and then completed a second-step merger, with Revance becoming wholly owned by Crown and delisted from Nasdaq.
-
L Catterton and Naomi Watts Acquire Stripes Beauty
June 24, 2024
Consumer Products
L Catterton, a consumer-focused investment firm, has partnered with actress and founder Naomi Watts to acquire Stripes Beauty, a DTC women's beauty and menopause wellness brand launched in 2022. The partnership will provide capital and operational support to accelerate product innovation, scale marketing and team growth, and expand domestically and into international channels such as QVC and Canada.
-
Crown Laboratories Acquires Xycrobe Therapeutics, Inc.
May 22, 2019
Biotechnology
Crown Laboratories, a privately held skin care company based in Johnson City, Tennessee, has acquired Xycrobe Therapeutics, a developer of skin microbiome-based biotherapeutic technology. Crown plans to integrate Xycrobe’s microbiome platform and scientific team into its R&D organization to expand therapeutic and consumer skin-care capabilities; financial terms were not disclosed.
-
Crown Laboratories Acquires Keri Brand from GlaxoSmithKline
May 1, 2019
Consumer Products
Crown Laboratories acquired the North American rights to the Keri skin care brand from GlaxoSmithKline and concurrently received an equity investment from Greenspring Associates. Existing investors Hildred Capital Partners and Montreux Equity Partners provided financing in connection with the transaction; financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.